May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...
May 23, 2017 12:13 pm UTC| Business
MIDLOTHIAN, Va., May 23, 2017 -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill Growth Hormone (GH) secretagogue, today...